$NH Narayana Hrudayalaya (Narayana Health) reported its highest-ever quarterly revenue in Q4 FY26

Narayana Hrudayalaya (Narayana Health) reported its highest-ever quarterly revenue in Q4 FY26 at ₹25,938 crore, up 75.8% YoY, driven by strong growth in India, Cayman Islands, and its newly acquired UK operations. Net profit rose 16.3% YoY to ₹2,283 crore, though margins compressed to 20.8% from 26.1% last year. 📊 Q4 FY26 Performance Highlights Consolidated Revenue: ₹25,938 crore (+75.8% YoY) Adjusted EBITDA: ₹5,394 crore (+40.3% YoY) EBITDA Margin: 20.8% (down from 26.1% YoY) Adjusted Net Profit (PAT): ₹2,283 crore (+16.3% YoY) EPS (Q4): ₹11.02 (+13.5% YoY) 🌍 Segment-Wise Revenue Segment Q4 FY26 Revenue YoY Growth India ₹12,505 crore +12.8% Cayman Islands ₹5,618 crore +47.9% UK (Practice Plus acquisition) ₹8,090 crore New contribution 📅 Full-Year FY26 Highlights Consolidated Revenue: ₹78,960 crore (+44% YoY) Adjusted EBITDA: ₹17,928 crore (+31% YoY) Adjusted PAT: ₹9,374 crore (+18.7% YoY) Annual Net Profit: ₹5,031 crore (audited) Dividend: Final dividend of ₹4.50 per share; record date July 17, 2026. ⚠️ Key Risks & Challenges Margin Compression: EBITDA margin fell 530 bps YoY due to UK integration costs and higher NHS staff expenses. Debt Load: Net debt rose to ₹22,397 crore, debt/equity ratio worsened to 1.29x after UK acquisition financing. Insurance Segment Losses: Widened 15x to ₹1,242 crore in FY26. 🚀 Strategic Outlook Capacity Expansion: Targeting 7,600 beds by FY30 (currently 5,451 beds across 20 facilities). UK Integration: Management confident of stabilizing margins and leveraging synergies by FY27. Funding Plans: Approval to raise up to ₹1,500 crore via debt securities for growth initiatives. ✅ In summary: Narayana Hrudayalaya delivered record-breaking revenue growth in Q4 FY26, fueled by international expansion, but faces margin pressures and rising debt. The company remains focused on scaling capacity and integrating its UK operations to sustain profitability